What question did this study set out to answer?

This review aims to integrate evidence on the roles of circulating microRNAs in breast cancer and their clinical applications.

March 13, 2026CancersOpen Access

Circulating MicroRNA in Breast Cancer

View Full Paper

Ask AI

Bookmark

This review aims to integrate evidence on the roles of circulating microRNAs in breast cancer and their clinical applications.
Conducted a literature review using PubMed from January 2000 to February 2026.
Searched for studies combining breast cancer with microRNA and various circulation terms.
Prioritized studies providing validated targets and clinical evidence for microRNAs.
Organized findings based on functional categories like metastasis and immune modulation.
miR-21 and miR-155 identified as prominent oncogenic microRNAs.
miR-205 frequently reported as a tumor-suppressive microRNA reduced in breast cancer.
Combined miRNA panels indicate potential for sensitive diagnostics.
Context-dependent effects observed between triple-negative and estrogen receptor-positive diseases.

No takes yet. Share an insight, caveat, or question.

This review demonstrates the potential of circulating microRNAs for diagnostics in breast cancer, suggesting implications for precision oncology.

Sturzu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

This review demonstrates the potential of circulating microRNAs for diagnostics in breast cancer, suggesting implications for precision oncology.